Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
41
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

119
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
119
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

229
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
229
Phase I Reactions: Reductive Reactions01:27

Phase I Reactions: Reductive Reactions

197
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
197
Community Based Intervention01:30

Community Based Intervention

38
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
38
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

160
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
160

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent Pharmacological Guidelines for Difficult-to-Treat Mental Disorders.

Journal of psychosocial nursing and mental health services·2026
Same author

Concerns About Gabapentinoids in Psychiatric Practice.

Journal of psychosocial nursing and mental health services·2026
Same author

Exploration of Extended-Release Lorazepam: Implications for Safe Nurse Practitioner Practice.

Journal of psychosocial nursing and mental health services·2025
Same author

Improving engagement for enhancing social capital in the older adult: An American Academy of Nursing consensus paper.

Nursing outlook·2025
Same author

Protecting our nursing and healthcare workers with comprehensive strategies for preventing violence and promoting safety: An American Academy of Nursing consensus paper.

Nursing outlook·2025
Same author

Treatment of Attention-Deficit/Hyperactivity Disorder With Stimulants: Reducing Harms.

Journal of psychosocial nursing and mental health services·2025

Related Experiment Video

Updated: Jun 21, 2025

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
08:05

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers

Published on: January 5, 2018

9.8K

Harm Reduction in Psychiatric Settings.

Karan Kverno

    Journal of Psychosocial Nursing and Mental Health Services
    |July 8, 2024
    PubMed
    Summary

    Harm reduction strategies, including FDA-approved medications, can help more individuals access treatment for substance use disorders like tobacco, alcohol, and opioid use. Nurse practitioners can utilize these resources to support patient choices and improve care access.

    Area of Science:

    • Public Health
    • Psychiatric Nursing
    • Pharmacology

    Background:

    • Public health initiatives have reduced stigma surrounding substance use disorders, increasing treatment seeking.
    • Despite increased demand, a significant gap exists between individuals seeking treatment and those receiving it.
    • Nurse practitioners require accessible resources to implement harm reduction strategies effectively.

    Purpose of the Study:

    • To outline harm reduction approaches for nurse practitioners in managing substance use disorders.
    • To discuss the role of U.S. Food and Drug Administration-approved medications in treatment.
    • To provide guidance on understanding patient options and facilitating informed choices.

    Main Methods:

    • Review of current public health strategies and available resources.

    More Related Videos

    A Procedure to Study the Effect of Prolonged Food Restriction on Heroin Seeking in Abstinent Rats
    10:35

    A Procedure to Study the Effect of Prolonged Food Restriction on Heroin Seeking in Abstinent Rats

    Published on: November 11, 2013

    11.1K
    A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence
    08:05

    A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence

    Published on: March 23, 2022

    2.5K

    Related Experiment Videos

    Last Updated: Jun 21, 2025

    A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
    08:05

    A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers

    Published on: January 5, 2018

    9.8K
    A Procedure to Study the Effect of Prolonged Food Restriction on Heroin Seeking in Abstinent Rats
    10:35

    A Procedure to Study the Effect of Prolonged Food Restriction on Heroin Seeking in Abstinent Rats

    Published on: November 11, 2013

    11.1K
    A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence
    08:05

    A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence

    Published on: March 23, 2022

    2.5K
  • Discussion of harm reduction principles in clinical practice.
  • Explanation of pharmacologic mechanisms for acute and maintenance treatment of substance use disorders.

    • Main Results:

    • Harm reduction offers a framework for addressing the treatment gap in substance use disorders.
    • FDA-approved medications are available for tobacco, alcohol, and opioid use disorders.
    • Resources exist to support nurse practitioners in applying harm reduction.

    Conclusions:

    • Nurse practitioners are key to expanding access to evidence-based substance use disorder treatment.
    • Harm reduction, incorporating medication-assisted treatment, is crucial for improving patient outcomes.
    • Further integration of harm reduction strategies can enhance the quality and accessibility of care.